ClinicalTrials.gg
RecruitingNCT03989245IMPACTUCCUpdated Apr 25, 2024

Measuring the Impact of Care in the Cognitive Behavioural Unit

An observational study in Severe Disruptive Behaviour Disorders, sponsored by Gérond'if. Recruiting at 1 site in France. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2024-04-25.

Sponsored by Gérond'if · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2020; still recruiting 6 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
588
Ages
70 Years and older
Sex
All
01

Study summary

The purpose of this study is to compare the rate of re-hospitalizations in relation to a disruptive behaviour disorder (at 3 and 6 months) between patients who have received care in Cognitive Behavioural Unity (UCC ) and those who have received care in Geriatric Follow-up and Rehabilitation Care Unit (SSR).

Read the detailed description

The purpose of this muliticentric non-interventional study is to compare the rate of re-hospitalization in relation to a disruptive behaviour disorder between patients receiving care in Cognitive Behavioural Unity UCC (target arm) and those who have received care in Geriatric Care Unit and Rehabilitation SSR (Control arm ).

At Inclusion (Month 0) : Inclusion of patients admitted in UCC or in geriatric SSR units for less than 8 days after obtaining of their non opposition.

Following data: Socio-educational Level, somatic and psychiatric comorbidities, classification of the type of dementia, evolution of nutritional status, biology (hemoglobin, creatinine, albuminemia), cognitive evaluation, treatment, pain assessment, assessment of disruptive behaviour disorders, discharge modalities, assistance plan, legal protection (before and after hospitalization), types of restraints, measurement of fall rates and their consequences, pathology and/or symptoms observed ( incidents) during hospitalization and vital status will be collected at inclusion and follow-up (1, 3 and 6 months ).

At 1 month (M1), exit from hospitalization (M1): Data provided by Investigator .

At 3 months (M3) and 6 months (M6) after discharge from hospital in UCC or SSR: Sponsor's Clinical Research Associateall call patient (or his legal representative) or to the primary caregiver or attending physician or EHPAD coordinating physician for collection of questionnaires.

02

Conditions studied

  • Severe Disruptive Behaviour Disorders

Keywords

  • Severe disruptive behaviour disorders
  • Cognitive Behavioural Unit
  • Geriatric Follow-up and Rehabilitation Care Unit
03

In context

Lead sponsor

Gérond'if is the lead sponsor of 35 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients receiving care in Cognitive Behavioural Unit (UCC ) and Geriatric Follow-up and Rehabilitation Unit (SSR)

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 70 ≥ years of age
  • Patient with severe disruptive behaviour disorders with a score (Frequency X Severity) >7 to at least one of the 7 items targeted on Clinician Neuropsychaitric Inventury (NPI-Es) scale
  • Patient who was not cared for in Cognitive Behavioural Unit (UCC) within 6 months prior to admission
  • Patient entered center less than 8 days
  • Affiliation to a social security scheme
  • Patient or legal representative has expressed his non-opposition

Exclusion criteria

Exclusion Criteria:

  • 70 \< years of age
  • Patient with no score (FXG) >7 to at least one of the 7 items targeted on Clinician Neuropsychaitric Inventury NPI-ES scale
  • Patient who was cared for in UCC within 6 months of admission
  • Entered Centre for 8 days or more
  • Not affiliated or entitled to a social security scheme
  • Patient or legal representative has expressed his opposition
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
588 participants (estimated)
Patient registry
No

Groups and cohorts

  • Target arm: UCC (Cognitive Behavioural Unit)

    Patients receiving care in Cognitive Behavioural Unit (UCC )

  • Control arm: SSR (Geriatric Follow-up and Rehabilitation Unit)

    Patients receiving care in Geriatric Follow-up and Rehabilitation Care Unit (SSR)

06

What researchers measure

Primary outcomes

  1. Compare the rate of re-hospitalizations in relation to a disruptive behaviour disorder according Clinician Neuropsychaitric Inventury (NPI-Es) scaleaccording

    Time frame: 6 months

Secondary outcomes

  1. Measuring cognitive impairment according Mini-Mental State Examination (MMSE) score

    Time frame: 6 months

  2. Screening for a nutritional disorder according Body Mass Index (BMI) score

    Time frame: 1 month

  3. Assessment of somatic-comorbidities according Charlson scale

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Psychiatric Geriatric Department, Bretonneau hospital
    Paris, Ile-de-France 75018, France
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2020 (actual). Primary completion is estimated for Jan 2025, 60 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2019
First posted
Jun 18, 2019
StartActual
Jan 20, 2020
Primary completionEst.
Jan 2025
CompletionEst.
Dec 2025
Last update
Apr 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03989245
Lead sponsor
Gérond'if
Responsible party
Sponsor
First posted
Jun 18, 2019
Start date
Jan 20, 2020
Primary completion
Jan 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Apr 25, 2024

Study contacts

Isabelle Dufour
Contact
isabelle.dufour@gerondif.org
+33 (0) 185781010
Prisca Lucas, PhD
Contact
prisca.lucas@gerondif.org
+33 (0) 185781010
Olivier Drunat, MD
study chair · Psychiatric Geriatric Department, Bretonneau hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion